Table 2 Follow-up Workflow
IE | FE | FU week 6 | FU month 6 | FU month 12 | FU month 18 | FU month 24 | FU month 36 | FU month 48 | FU month 60 | |
|---|---|---|---|---|---|---|---|---|---|---|
In−/exclusion criteria fulfilled | x | |||||||||
Informed consent | x | |||||||||
Medical history/findings | x | x | x | x | x | x | x | x | x | |
Karnofsky performance index | x | x | x | x | x | x | x | x | x | |
Height | x | |||||||||
Weight | x | x | x | x | x | x | x | x | x | |
QLQ-C30 and QLQ-H&N35 | x | x | x | x | x | x | x | x | x | x |
Symptoms/Toxicities (CTC AE v5.0) | x | x | x | x | x | x | x | x | x | x |
Documentation staging examination | x | |||||||||
MRI | x | x | x | x | x | x | x | x | x | |
CT chest | x | x | x | x | x | x | ||||
CT/Sonography Liver | x | |||||||||
Bone scintigraphy | x | |||||||||
Scheduling FU | x |